Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis

Journal of Rheumatology

Volumn 37, Issue 1, 2010, Pages 209-

  Rottem, Menachem ^a   Mader, Reuven ^b,c  

^a Allergy Immunology and AIDS Center   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATINE KINASE; DANAZOL; ETANERCEPT; FRESH FROZEN PLASMA; HIGH DENSITY LIPOPROTEIN; LERCANIDIPINE; METHOTREXATE; ROSUVASTATIN; SALAZOSULFAPYRIDINE; TRANEXAMIC ACID; TRIACYLGLYCEROL;

ADULT; ANGIONEUROTIC EDEMA; BLEEDING TIME; BLOOD CLOTTING TIME; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DISEASE DURATION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LABORATORY TEST; LETTER; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOEDEMA; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 73649113102     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090686     Document Type: Letter

References (5)

1. Széplaki G, Varga L, Szépvölgyi A, Simon K, Blaskó B, Nagy E, et al. Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency. Int Arch Allergy Immunol 2008;146:164-8.
2. Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 2008;8:156-9.
3. Wakamoto S, Fujihara M, Sakagawa H, Takahashi D, Niwa K, Morioka M, et al. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Transfusion 2008;48:2060-8.
4. Epstein TG, Bernstein JA. Current and emerging management options for hereditary angioedema in the US. Drugs 2008;68:2561-73.
5. Frank MM, Jiang H. New therapies for hereditary angioedema: disease outlook changes dramatically. J Allergy Clin Immunol 2008;121:272-80.